Uncategorised - European Medical Journal

Air Pollution Linked to Elevated Risk of Fatty Liver Disease

Learn how new research links major air pollutants with increased NAFLD risk, urging broader public health focus.

Scalp Metastases from Breast Cancer Show Distinct Dermoscopic Patterns

Scalp cutaneous metastases from breast carcinoma may present with varied clinical patterns, and new research highlights distinct dermoscopic features that could aid earlier recognition.

Artificial Sweeteners Linked to Faster Memory Loss and Cognitive Decline

Frequent use of artificial sweeteners may speed up memory loss and thinking decline, particularly for those with diabetes.

Novo Nordisk cuts jobs to fund diabetes and obesity growth

Novo Nordisk announces 9,000 job cuts to streamline operations and reinvest in diabetes and obesity growth, aiming for long-term efficiency.

Study Finds Virtual Rheumatology Care Effective With Low Failure Rates

A study of 226 patients shows virtual rheumatology care is safe and effective, with very low rates of failed visits and no increase in disease-related hospitalizations.

Large Study Finds Fertility Knowledge Gaps in UK Women

A study of nearly 100,000 UK women trying to conceive revealed that 41% could not correctly identify their fertile window, underscoring the urgent need for improved fertility education.

Advancing Ovarian Cancer Care with 3D Micro-Tumour Testing

A recent study introduces an advanced ex vivo 3D micro-tumour testing platform that accurately forecasts individual patient response to chemotherapy, potentially revolutionizing personalized treatment decisions.

One in Five School Children Lack Full Vaccine Protection

New UKHSA data show pre-school booster coverage has fallen to 81.4% in England, below herd immunity thresholds, leaving children vulnerable to outbreaks.

5 minutes with Fabrice Chouraqui, CEO, Pharming

Pharming’s CEO explores his journey into the pharmaceutical industry, a typical day for a CEO and his thoughts on leadership.

Monoclonal Antibody Cuts Bleeding Risk in Atrial Fibrillation with Kidney Disease

Abelacimab reduces bleeding risk in atrial fibrillation patients, even with kidney disease, study finds.